Abstract
The present study was conducted to compare the therapeutic regimens of low-dose mifepristone (200 mg) plus vaginal meteneprost versus oral misoprostol in terms of efficacy and safety for medical termination of early pregnancy. A randomized clinical trial was conducted by the Department of Obstetrics and Gynecology at the All India Institute of Medical Sciences, New Delhi. A total of 101 subjects were enrolled within 56 days of amenorrhea. A single dose of 200 mg of mifepristone (RU 486) was given and, 48 hr later, prostaglandin was administered as either 5 mg of 9-methylene PGE2 vaginal gel, meteneprost (classified as group I) or 600 μg of oral PGE1 derivative misoprostol (classified as group II). In group I, 50 subjects and in group II, 51 subjects were treated with the respective schedule. The success rate with mifepristone + misoprostol (group II) was 88.63% which was significantly higher than that with mifepristone + meteneprost (group I) which was 82% (p<0.05). The average duration of bleeding in cases with complete abortion was 8.95±5.67 and 9.77±6.51 in group I and II, respectively. There were no serious side-effects. Only one subject in group I (2%) required blood transfusion for heavy bleeding. This study indicated that oral prostaglandin after a low dose of mifepristone (200 mg) could be developed into an effective method to terminate early pregnancy. Oral administration of both drugs would be a more convenient, feasible, private and acceptable regimen.
Similar content being viewed by others
References
UK Multicentric Trial. The efficacy and tolerance of mifepristone and prostaglandin, in first trimester termination of pregnancy. Br J Obstet Gynaecol. 1990;97:480-6.
Tietze C. Induced Abortion. A World Review 1981. A Population Council Fact Book. New York: The Population Council, 1981; 41-113.
Karim SMM, Rao B, Ratnam SS, Prasad RNW, Wong YM, Vancheran A. Termination of early pregnancy (menstrual induction) with 16-phenoxy-17,18,19,20 letvanor PGE2 methyl sulfomylamide. Contraception. 1977;16:377-81.
Bachelot A, Cludy L, Spina A. Conditions for choosing between drug induced and surgical abortions. Contraception. 1992;45(6)547-59.
Norman JE, Thong KJ, Baird DT. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet. 1991;358(160:1233-6.
Anon A. Death associated with mifepristone/sulprostone. Lancet. 1991;337:969-70.
Kalra PA, Litherland D, Sallomi DF, Critchley HOD, Faleener GF, Holmes AM. Cardiac stand still induced by prostaglandin pessaries. Lancet. 1989;1:1960-1.
Swahn ML, Ugocsia G, Bygdeman M, Kovaco L, Belsy EM, Vanhook PFA. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment on women receiving RU486 (mifepristone) for termination of early pregnancy. Hum Reprod. 1989;4:21-8.
Aubery E, Baulieu EE. Contraceptive activity of RU 486 and orally active prostaglandin in combination. CR Acad Sci III. 1991;312:539-45.
World Health Organization. Termination of early human pregnancy with RU 486 (mifepristone) and the prostaglandin analogue sulprostone, a multicentric, randomised comparison between two treatment regimens. Hum Reprod. 1989;4:718-25.
Indian Council of Medical Research, Task Force on Hormonal Contraception. A multicentric clinical trial with RU 486 by a methylene PGE2 vaginal gel for termination of early pregnancy. A close finding study. Contraception. 1994;49:87-98.
Roger MW, Baird DT. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary. Lancet. 1987;2:1415-18.
Silvestre L, Dubois C, Renault M, Rezvani Y, Banlieu EE, Glman A. Voluntary interruption of pregnancy with mifepristone (RU 486) and prostaglandin analogue. N Engl J Med. 1990;322:645-8.
Roger MW, Logan AF, Baird DT. Induction of early abortion with mifepristone (RU 486) and two different doses of prostaglandin pessary (gameprost). Contraception. 1989;39(5):497-502.
Ulman A, Silvestre L, Chemama L. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Acta Obstet Gynecol Scand. 1992;71:278-83.
Peyron R, Aubeny E, Tarosz V et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med. 1993;338(2):1509-13.
Swalin ML, Gottlieb C, Green K, Bygdeman M. Oral administration of RU 486 + 9 methylene PGE2 for termination of early pregnancy. Contraception. 1990;41:461-73.
Prasad RNV, Choolani M. Termination of early human pregnancy with either 50 mg or 200 mg single oral dose of mifepristone (RU486) in combination with either 0.5 mg of 1.0 mg vaginal gemeprost. Aust NZ J Obstet Gynaecol. 1996;36(1):20-3.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takkar, D., Agarwal, N., Sehgal, R. et al. Early abortion by mifepristone (RU 486) followed by vaginal gel (meteneprost) versus oral (misoprostol) prostaglandin. Advances in Contraception 15, 163–173 (1999). https://doi.org/10.1023/A:1006753827740
Issue Date:
DOI: https://doi.org/10.1023/A:1006753827740